|
|
Blood, 1 August 2005, Vol. 106, No. 3, pp. 1084-1091.
Prepublished online as a Blood First Edition Paper on April 14, 2005; DOI 10.1182/blood-2004-12-4703.
 Previous Article | Table of Contents | Next Article 
RED CELLS
Microcytic anemia, erythropoietic protoporphyria, and neurodegeneration in mice with targeted deletion of iron-regulatory protein 2
Sharon S. Cooperman,
Esther G. Meyron-Holtz,
Hayden Olivierre-Wilson,
Manik C. Ghosh,
Joseph P. McConnell, and
Tracey A. Rouault
From the National Institute of Child Health and Human Development, Bethesda, MD; and The Mayo Clinic and Foundation, Rochester, MN.
Iron-regulatory proteins (IRPs) 1 and 2 posttranscriptionally regulate expression of transferrin receptor (TfR), ferritin, and other iron metabolism proteins. Mice with targeted deletion of IRP2 overexpress ferritin and express abnormally low TfR levels in multiple tissues. Despite this misregulation, there are no apparent pathologic consequences in tissues such as the liver and kidney. However, in the central nervous system, evidence of abnormal iron metabolism in IRP2-/- mice precedes the development of adult-onset progressive neurodegeneration, characterized by widespread axonal degeneration and neuronal loss. Here, we report that ablation of IRP2 results in iron-limited erythropoiesis. TfR expression in erythroid precursors of IRP2-/- mice is reduced, and bone marrow iron stores are absent, even though transferrin saturation levels are normal. Marked overexpression of 5-aminolevulinic acid synthase 2 (Alas2) results from loss of IRP-dependent translational repression, and markedly increased levels of free protoporphyrin IX and zinc protoporphyrin are generated in IRP2-/- erythroid cells. IRP2-/- mice represent a new paradigm of genetic microcytic anemia. We postulate that IRP2 mutations or deletions may be a cause of refractory microcytic anemia and bone marrow iron depletion in patients with normal transferrin saturations, elevated serum ferritins, elevated red cell protoporphyrin IX levels, and adult-onset neurodegeneration.
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati What's this?
Related Article in Blood Online:
-
Iron regulatory protein 2 and anemia
- Victor R. Gordeuk
Blood 2005 106: 774-775.
[Full Text]
[PDF]
This article has been cited by other articles:
|
|
|
|
 
K. B. Zumbrennen, M. L. Wallander, S. J. Romney, and E. A. Leibold
Cysteine Oxidation Regulates the RNA-Binding Activity of Iron Regulatory Protein 2
Mol. Cell. Biol.,
April 15, 2009;
29(8):
2219 - 2229.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. Iolascon, L. De Falco, and C. Beaumont
Molecular basis of inherited microcytic anemia due to defects in iron acquisition or heme synthesis
Haematologica,
March 1, 2009;
94(3):
395 - 408.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. Ferring-Appel, M. W. Hentze, and B. Galy
Cell-autonomous and systemic context-dependent functions of iron regulatory protein 2 in mammalian iron metabolism
Blood,
January 15, 2009;
113(3):
679 - 687.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
N. C. Andrews
Forging a field: the golden age of iron biology
Blood,
July 15, 2008;
112(2):
219 - 230.
[Full Text]
[PDF]
|
|
|
|
|
|
|
F. Missirlis, S. Kosmidis, T. Brody, M. Mavrakis, S. Holmberg, W. F. Odenwald, E. M. C. Skoulakis, and T. A. Rouault
Homeostatic Mechanisms for Iron Storage Revealed by Genetic Manipulations and Live Imaging of Drosophila Ferritin
Genetics,
September 1, 2007;
177(1):
89 - 100.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
W. Wang, X. Di, R. B. D'Agostino Jr., S. V. Torti, and F. M. Torti
Excess Capacity of the Iron Regulatory Protein System
J. Biol. Chem.,
August 24, 2007;
282(34):
24650 - 24659.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. Beaumont
Heme/Fe-S intimacies make RBCs blush
Blood,
August 15, 2007;
110(4):
1085 - 1086.
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. Camaschella, A. Campanella, L. De Falco, L. Boschetto, R. Merlini, L. Silvestri, S. Levi, and A. Iolascon
The human counterpart of zebrafish shiraz shows sideroblastic-like microcytic anemia and iron overload
Blood,
August 15, 2007;
110(4):
1353 - 1358.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. Cavadini, G. Biasiotto, M. Poli, S. Levi, R. Verardi, I. Zanella, M. Derosas, R. Ingrassia, M. Corrado, and P. Arosio
RNA silencing of the mitochondrial ABCB7 transporter in HeLa cells causes an iron-deficient phenotype with mitochondrial iron overload
Blood,
April 15, 2007;
109(8):
3552 - 3559.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. Wang, C. Fillebeen, G. Chen, A. Biederbick, R. Lill, and K. Pantopoulos
Iron-Dependent Degradation of Apo-IRP1 by the Ubiquitin-Proteasome Pathway
Mol. Cell. Biol.,
April 1, 2007;
27(7):
2423 - 2430.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. Zhang, E. Meyron-Holtz, and T. A. Rouault
Renal Iron Metabolism: Transferrin Iron Delivery and the Role of Iron Regulatory Proteins
J. Am. Soc. Nephrol.,
February 1, 2007;
18(2):
401 - 406.
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Schranzhofer, M. Schifrer, J. A. Cabrera, S. Kopp, P. Chiba, H. Beug, and E. W. Mullner
Remodeling the regulation of iron metabolism during erythroid differentiation to ensure efficient heme biosynthesis
Blood,
May 15, 2006;
107(10):
4159 - 4167.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. Wang, C. Fillebeen, G. Chen, B. Andriopoulos, and K. Pantopoulos
Sodium Nitroprusside Promotes IRP2 Degradation via an Increase in Intracellular Iron and in the Absence of S Nitrosylation at C178.
Mol. Cell. Biol.,
March 1, 2006;
26(5):
1948 - 1954.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
B. Galy, D. Ferring, B. Minana, O. Bell, H. G. Janser, M. Muckenthaler, K. Schumann, and M. W. Hentze
Altered body iron distribution and microcytosis in mice deficient in iron regulatory protein 2 (IRP2)
Blood,
October 1, 2005;
106(7):
2580 - 2589.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
